Source: Annual Congress 2005 - Exploring alternative mechanisms and treatments
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. S. Kwon, J. H. Ahn, S. J. Kim, S. Y. Lee, Y. K. Kim, K. H. Kim, H. S. Moon, J. S. Song, S. H. Park (Seoul, Republic Of Korea). The effect of BCG treatment on the remodelling in the house dust mite induced allergic asthma in mice. Eur Respir J 2005; 26: Suppl. 49, 3716

Member's Comments

No comment yet.

Related content which might interest you: Effect of house dust mite sublingual immunotherapy on airway inflammation and remodeling in allergic asthma with rhinitis Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 Calcaratarin D attenuates house dust mite-induced allergic asthma Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 The effect of montelukast during allergen sensitization period in house dust mite mouse model Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 Impact of symbicort® on established airway inflammation and remodeling in mice chronically exposed to house dust mite extract Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology Year: 2004 Cigarette smoke exposure facilitates allergic sensitization to house dust mite and aggravates the asthmatic phenotype in mice Source: Annual Congress 2012 - Mechanisms of asthma Year: 2012 A house dust mite-induced asthma model in transcutaneously sensitized mice Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Association between Th2 biomarker levels and efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Sublingual immunotherapy is an established therapy for house dust mite sensitive allergic rhinitis and/or asthma Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 The reduction of the house dust mite as a prevention component in a treatment of the asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 335s Year: 2002 House dust mite sublingual immunotherapy reduces type 2 biomarkers in allergic asthma Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020 Poly:IC causes exacerbation in a murine allergic inflammation model driven by house dust mite in Freund‘s complete adjuvant Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012 Monitoring spirometry-like parameters in mice with house dust mite-induced experimental asthma Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021 Hypoallergenic high dose scit as add-on therapy in children with allergic asthma caused by house dust mites Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009 Efficacy of specific allergy vaccination in house dust mite asthma Source: Eur Respir J 2005; 26: Suppl. 49, 465s Year: 2005 Young Investigator session: Inhibition of airway hyperresponsiveness and inflammation by vaccination against IL-33 in a house dust mite model of asthma Source: Lung Science Conference 2014 - Lung Inflammation and Immunity Year: 2014 Inflammatory and remodeling events in a murine model of asthma according to chronic exposure to house dust mite Source: Eur Respir J 2007; 30: Suppl. 51, 368s Year: 2007 Correlation between nasal eosinophilic inflammation and bronchial reactivity to methacholine in allergic children sensitized to house dust mites (HDM) Source: Eur Respir J 2002; 20: Suppl. 38, 172s Year: 2002 Sensitisation to house dust mite: its association with bronchial hyperresponsiveness and lung function in asthmatic children Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Exposure to higher levels of house dust mite allergen and endotoxin is not associated with respiratory symptoms and severity of AHR in older asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 454s Year: 2002 Allergen exposure in nondog and nonhouse dust mite sensitized atopic asthmatic subjects; effect on bronchial reactivity Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001